Submission of the manuscript is online via e-mail
ecgarticle@gmail.com or
cholerez@mail.ru

Tel: +7 903 250 5288

Editorial Correspondence e-mail
gastrossr@gmail.com


Publishing, Subscriptions, Sales and Advertising, Correspondence e-mail
journal@cniig.ru

Tel: +7 917 561 9505

SCImago Journal & Country Rank

    1. Leningrad regional clinical hospital (St. Petersburg, Russian Federation)
    2. SSC LM them. O. K. Skobelkin FMBA of Russia (Moscow, Russian Federation)
    3. Peoples friendship University of Russia (Moscow, Russian Federation)

    Keywords: laterally spreading tumor, endoscopic mucosal resection, control of the removal of the focus of residual tumor tissue, ZOOM, argon-plasma coagulation

    Abstract:The removal of the laterally spreading tumor is a radical method of its treatment; it is necessary to control the completeness of LST removal using ZOOM and destruction of residual tumor tissue by argon-plasma coagulation to prevent recurrence of the tumor.

      1. Sakamoto T, Saito Y, Nakamura F, Abe S, Takamaru H, Sekiguchi M, Yamada M, Nakajima T, Matsuda T, Yamagishi H, Kato H. Short-term outcomes following endoscopic submucosal dissection of large protruding colorectal neoplasms. Endoscopy. 2017 Dec 13. doi: 10.1055/s-0043-123578.
      2. Mizushima T, Kato M, Iwanaga I, Sato F, Kubo K, Ehira N, Uebayashi M, Ono S, Nakagawa M, Mabe K, Shimizu Y, Sakamoto N. Technical difficulty according to location, and risk factors for perforation, in endoscopic submucosal dissection of colorectal tumors. Surg Endosc. 2015 Jan;29(1):133-9. doi: 10.1007/s00464-014-3665-9.
      3. Князев М.В., Дуванский В. А. Эндоскопическая резекция слизистой с диссекцией подслизистого слоя - 20 лет спустя (обзор зарубежной литературы) // Экспериментальная и клиническая гастроэнтерология. -2015. № 4 (116). С. 53-58.
      4. Saito Y, Uraoka T, Yamaguchi Y, Hotta K, Sakamoto N, Ikematsu H, Fukuzawa M, Kobayashi N, Nasu J, Michida T, Yoshida S, Ikehara H, Otake Y, Nakajima T, Matsuda T, Saito D. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc. 2010 Dec;72(6):1217-25. doi: 10.1016/j.gie.2010.08.004
      5. Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy. 1993; 25:455-461
      6. Nakajima T, Saito Y, Tanaka S, Iishi H, Kudo S.E, Ikematsu H, Igarashi M, Saitoh Y, Inoue Y, Kobayashi K, Hisasbe T, Matsuda T, Ishikawa H, Sugihara K Current status of endoscopic resection strategy for large, early colorectal neoplasia in Japan. Surg Endosc. 2013 Sep;27(9):3262-70. doi: 10.1007/s00464-013-2903-x
     


    Full text is published :
    Chernykh D.A., Myaukina L.M., Filin A.A., Duvanskiy V.A. CONTROL OF THE COMPLETENESS REMOVAL LATERALLY SPREADING TUMOR (LST). Experimental and Clinical Gastroenterology Journal. 2018;152(04):99-100
    Read & Download full text

    1. The Federal State Budgetary Scientific Institution «Petrovsky National Research Center of Surgery» (Moscow, Russian Federation)

    Keywords: inflammatory myofibroblastic tumor, endoscopic ultrasonography, common bile duct (CBD), ERCP, EPST

    Abstract:Aim: The inflammatory myofibroblastic tumor (IMT) is rare and has an intermediate malignancy in terms of local invasiveness. There are pulmonary and extrapulmonary forms that are rare to be come across. Among extrapulmonary forms, biliary lesion occurs in isolated instances. Due to the rarity of the disease, we provide our own clinical observation. In a 35-year-old patient various instrumental methods showed the formation in the distal common bile duct (CBD), which manifested the painless form of jaundice. The presence of tissue mass in the distal CBD is often associated with malignant neoplasms. One of the informative instrumental techniques turned out to be endosonography and endoscopic retrograde therapeutic and diagnostic interventions on extrahepatic bile ducts with biopsy sampling. Due to the rarity of the disease and the precaution regarding the malignant origin of the neoplasm in the distal CBD, the patient underwent a surgery. Histological and immunohistochemical data confirmed the inflammatory myofibroblastic tumor.

      1. Dubova E. А., Pavlov K. А., Frank G. А., Shhegolev А. I. Vospalitel’naya miofibroblasticheskaya opukhol’ pecheni [Inflammatorymiofibroblastiсliver tumor]. Аrkh patol 2009; 3:25–28. (In Russian)
      2. Frank G. А. Problemy morfologicheskoj klassifikatsii i diagnostiki opukholej myagkikh tkanej [Problems of morphological classification and diagnosis of soft tissue tumors]. Prakticheskaya onkologiya 2004; 5: 4: 231–236. (In Russian)
      3. Coffin C.M., Hornick J. L., Fletcher C. D. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007; 31: 4: 509–520.
      4. Popov S. D., Il’ina N. A. Inflammatory myofibroblasts tumor of the lung: Problems in differential diagnosis. Journal of radiology and nuclear medicine. 2013; 6: 38–43
      5. Patnana M., Sevrukov А., Elsayes K. M. et al. Inflammatory Pseudotumor: The Great Mimicker. Am J Roentgenol 2012; 198: 217–227.
      6. Pack G.T., Baker H. W. Total right hepatic lobectomy: report of a case. Ann Surg 1953; 138: 53–58.
      7. Lopez-Tomassetti Fernandez E. M., Luis H. D., Malagon A. M., Gonzalez I. A., Pallares A. C. Recurrence of inflammatory pseudotumor in the distal bile duct: lessons learned from a single case and reported cases. World J Gastroenterol. 2006 Jun 28; 12 (24): 3938–3943.
      8. Arpacı E., Yetişyiğit T., Ulaş A. et al. A case of intraabdominal myofibroblastic tumor with aggressive behavior. Turkish Journal of Oncology 2010; 25: 1: 28–32.
      9. Gleason B.C., Hornick J. L. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 2008; 61: 428–437.
      10. Kim K., Park C., Lee J. et al. Inflammatory myofibroblastic tumor of the stomach with peritoneal dissemination in a young adult: imaging findings. Abdom Imaging 2004; 29: 9–11.
      11. Hosler G.A., Steinberg D. M., Sheth S. et al. Inflammatory pseudotumor: a diagnostic dilemma in cytopathology. Diagnostic Cytopathology 2004; 4: 267–270.
      12. Shi H., Wei L., Sun L., Guo A. Primary gastric inflammatory myofibroblastic tumor: A clinicopathologic and immunohistochemical study of 5 cases. Pathol Res Pract 2010; 206: 5: 287–291.
      13. Butrynski J.E., D’Adamo D.R., Hornick J. L. et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 2010; 363: 18: 1727–1733.
      14. Cook J.R., Dehner L. P., Collins M. H., Ma Z., Morris S. W., Coffin C. M. et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol. 2001; 25: 1364–1371.
      15. Kim B.S., Joo S. H., Kim G. Y., Joo K. R. Aggressive hilar inflammatory myofibroblastic tumor with hilar bile duct carcinoma in situ. J Korean Surg Soc. 2011 Dec; 81 Suppl 1: S59–63. doi: 10.4174/jkss.2011.81.Suppl1.S59. Epub 2011 Nov 25.
      16. Martín Malagón A., López-Tomassetti Fernández E., Arteaga González I., Carrillo Pallarés A., Díaz Luis H. Inflammatory myofibroblastic tumor of the distal bile duct associated with lymphoplasmacytic sclerosing pancreatitis. Case report and review of the literature. Pancreatology. 2006; 6 (1–2): 145–54.
      17. Rosenbaum L., Fekrazad M. H., Rabinowitz I., Vasef M. A. Epstein-Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature. J Hematop. 2009; 2: 127–131.
      18. Dehner L.P., Coffin C. M. Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. Semin Diagn Pathol. 1998 May; 15 (2): 161–173.
      19. Sim A, Lee MW, Nguyen GK. Inflammatory myofibroblastic tumour of the pancreas. Can J Surg.2008; 51: E23-E24.
      20. Pungpapong S., Geiger X. J., Raimondo M. Inflammatory myofibroblastic tumor presenting as a pancreatic mass: a case report and review of the literature. JOP. 2004; 5: 360–367.
      21. Ashcroft M.W., Ng C. S., Frost R. A., Freeman A. H. Biliary inflammatory pseudotumour: report of two cases and review of the literature. Clin Radiol. 2009; 64: 449–455.
      22. Büyükyavuz I., Karnak I., Haliloglu M., Senocak M. E. Inflammatory myofibroblastic tumour of the extrahepatic bile ducts: an unusual cause of obstructive jaundice in children. Eur J Pediatr Surg. 2003 Dec; 13 (6): 421–4.
      23. Kwak J.W., Paik C. N., Jung S. H., Chang U. I., Lee K. M., Chung W. C., Yoo J. Y., Yang J. M. An inflammatory myofibroblastic tumor of the ampulla of vater successfully managed with endoscopic papillectomy: report of a case. Gut Liver. 2010 Sep; 4(3): 419–22.
      24. Stuckmann G., Flury R., Heinz W., Strunk H. Inflammatory myofibroblastic tumour (so-called pseudotumour) of the hepatobiliary system. Ultraschall Med. 2004 Sep; 25(5): 373–6.
      25. Rastogi A., Bihari C., Gupta N., Deka P., Kumar A., Negi S. S., Arora A. Hilar Inflammatory Pseudotumour with Hepatic Artery Atheroma-mimicker of Klatskin Tumour. Indian J Surg Oncol. 2015 Mar; 6(1): 86–89.
      26. Venkataraman S., Semelka R. C., Braga L., Danet I. M., Woosley J. T. Inflammatory myofibroblastic tumor of the hepatobiliary system: report of MR imaging appearance in four patients. Radiology. 2003; 227: 758–763.
      27. Donner L.R., Trompler R. A., White R. R. 4th Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into sarcoma after several recurrences. Hum Pathol. 1996; 27: 1095–1098.
     


    Full text is published :
    Godzhello E. A., Khrustaleva M. V., Bulganina N. A., Dekhtyar M. A. ENDOSCOPIC DIAGNOSIS OF THE DISTAL COMMON BILE DUCT MYOFIBROBLASTIC TUMOR IN THE35-YEAR-OLD PATIENT. Experimental and Clinical Gastroenterology Journal. 2018;152(04):101-106
    Read & Download full text

    1. Fgbu “Institute of surgery. A. V. Vishnevsky” (Moscow, Russian Federation)

    Keywords: ERCP, endoscopic treatment, iatrogenic strictures, posttraumatic strictures, strictures of bile ducts, stenting, plastic stents, complications

    Abstract:Introduction. Iatrogenic bile duct injury continues to be one of the most important clinical problems in surgery. Due to the development of non-surgical ways of treatment, bile duct injury is mainly managed endoscopiccally. Materials and methods. 53 y. o. female patient was admitted in April of 2015. According to the anamnesis - laparoscopic cholecystectomy in February 2015, complicated with the injury of the right hepatic duct (clipped and cut). MRCP- right hepatic duct is blocked by the confluence. 27.04.2015 ERCP, ERS, ballon dilatation of the stump and placement of the 7Fr stent in the right hepatic duct. Results. Until May 2016 the patient had 3 restenting operations on the right hepatic duct with the bigger stent each time (8.5, 10 Fr). The last ERCP was finished with the removal of the plastic stent. During the contrast study the diameter of the duct in the structure area was 4 mm. The patient is monitored with no relapse for 1 year and 6 months. Conclusions. Minimally invasive endoscopic treatment of iatrogenic bile duct injuries with a step by step stenting is more preemptive then open reconstruction surgical procedures.

      1. Walsh R.M., Henderson J. M., Vogt D. P., Brown N. Long-term outcome of biliary reconstruction for bile duct injuries from laparoscopic cholecystectomies. // Surgery, 2007. 142(4): p. 450-6; discussion 456-7
      2. Reuver P.R., Sprangers M. A., Rauws E. A. et al. Impact of bile duct injury after laparoscopic cholecystectomy on quality of life: a longitudinal study after multidisciplinary treatment. // Endoscopy, 2008. 40(8): p. 637-43.
      3. Gal’perin E.I., Kuzovlev N. F., Karagyulyan S. R. Rubtsovyye striktury zhelchnykh protokov [Cicatricial stricture of the bile duct] Moscow, Medicine Publ., 1982. 240 p.
      4. Borisov A. E. Rukovodstvo po khirurgii pecheni i zhelchevyvodyashchikh putey [Руководство по хирургии печени и желчевыводящих путей]. St. Petersburg: Scythia, 2003. 488 p.
      5. Milonov O. B., Movchun A. A. Vosstanovitel’nyye i rekonstruktivnyye operatsii na zhelchnykh protokakh. Rekonstruktivnaya khirurgiya i transplantologiya organov [Restorative and reconstructive operations on the bile ducts. Reconstructive surgery and organ transplantation.] Mocsow, 1973. 115–116 p.
      6. Nechay A. I., Novikova K. V. Prichiny i predraspolagayushchiye obstoyatel’stva sluchaynykh povrezhdeniy zhelchnykh protokov pri kholetsistoektomii i rezektsii zheludka [Causes and predisposing circumstances of accidental bile duct damage in cholecystectomy and gastrectomy]. Vestnik khirurgii – Bulletin surgery, 1991, no.1, pp.15–21 (in Russian).
      7. Petrovskiy B. V., Milonov O. B., Smirnov V. A. Rekonstruktivnaya khirurgiya pri porazhenii vnepechenochnykh zhelchnykh protokov [Reconstructive surgery for lesion of extrahepatic bile ducts]. Moscow, 1980. 304 p.
      8. Savel’ev V.S., Moguchev V. M., Filimonov M. I. 1971. Damage to the main biliary ducts during cholecystectomy. Khirurgiya. [Surgery] 5: 47–51. (in Russian).
      9. Shalimov A. A. et al. Khirurgiya pecheni i zhelchnykh protokov [Surgery of the liver and bile ducts]. Kiev, Health Publ., 1975. 407 p.
      10. Thompson C.M., Saad N. E., Quazi R. R. et al. Management of iatrogenic bile duct injuries: role of the interventional radiologist. // Radiographics, 2013. 33(1): p. 117–34.
      11. Adler DG, Papachristou GI, Taylor LJ, McVay T, Birch M, Francis G, Zabolotsky A, Jaique SN, Hayat U, Zhan T, Das R, Slivka A, Rabinovitz M, Munigala S, SiddiquiAA. Clinical outcomes in patients with bile leaks treated via ERCP: a large multicenter study. Gastrointest Endosc.2016 Aug 26. pii: S0016–5107(16)30524–7.
     


    Full text is published :
    Starkov Y.G., Viborny M.I., Dzhantuhanova S.V., Andreytseva O.I., Hon E.I. ENDOSCOPIC SURGICAL TREATMENT OF INJURIES OF THE RIGHT LOBAR BILE DUCT IN A PATIENT OF 53 YEARS. Experimental and Clinical Gastroenterology Journal. 2018;152(04):107-110
    Read & Download full text